CompletedNot applicableNCT02399007

A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China

Studying Avascular necrosis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Johnson & Johnson Medical (Suzhou) Ltd.
Principal Investigator: Shigui Yan, DDS, MSD
The second Affiliated Hospital of Zhejiang Medicine University
Intervention: Total Hip System made in China (SUN, CoCr, Duraloc, Marathon)(device)
Enrollment: 160 enrolled
Eligibility: 55-80 years · All sexes
Timeline: 2015 – 2018

Study locations (8)

The first affiliated hospital of Guangzhou Tranditional Meidical University, Guangzhou, Guangdong, China
The third affiliated hospital of Hebei University, Shijiazhuang, Hebei, China
The second affiiliated hospital of Harbin Medical University, Harbin, Heilongjiang, China
The first affiliated hospital of Nanchang University, Nanchang, Jiangxi, China
The affiliated hosoital of Ningxia Medical University, Yinchuan, Ningxia, China
The First Affiliated Hospital of Xinjiang Medicine University, Hohhot, Xinjiang, China
The general hospital of Kunming, Kunming, Yunnan, China
The second Affiliated Hospital of Zhejiang Medicine University, Hangzhou, Zhejiang, China

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02399007 on ClinicalTrials.gov

Other trials for Avascular necrosis

Additional recruiting or active studies for the same condition.

See all trials for Avascular necrosis →

← Back to all trials